• No results found

FLT3 inhibitors in acute myeloid leukemia

N/A
N/A
Protected

Academic year: 2020

Share "FLT3 inhibitors in acute myeloid leukemia"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1 Clinical trials of sorafenib for AML therapy
Table 2 Clinical trials of sorafenib in hematopoietic stem cell transplantation
Table 3 Clinical trials of lestaurtinib for AML
Table 4 Clinical trials of midostaurin for AML therapy
+3

References

Related documents

Umbilicus intermedius boiss has the inhibitory properties against the black fungi. Furthermore, it is found that mixing with culture medium method is more

 For linking universities effectively to development, a country needs various forms and methods of knowledge policy coordination..  The connections between the larger policy

especially in the saliva of diabetics with periodontal disease, significantly higher than in systemically healthy subjects with periodontal disease and controls, confirming

On the basis of the few large population-based surveys available, the prevalence of elevated blood pressure is fairly high in several populations, whereas there is little

The frequency and nature of the mutations in UNC93A in ovarian tumours and cell lines suggests the following. Firstly, UNC93A is an unusual gene which is highly poly- morphic and

The study described in this paper will aim to evaluate lower limb muscle morphology and function of distance runners who do and do not develop MTSS in order to identify

Abstract: Electronic Nose (eNose) systems are particularly appreciated for their portability, usability, relative low cost and real-time or near real-time response. Their